Table of Contents
Epidemiology Research International
Volume 2015, Article ID 630812, 5 pages
http://dx.doi.org/10.1155/2015/630812
Research Article

Distribution of Human Leishmaniasis (VL) and Its Associated Risk Factors, in Metemma, Ethiopia

1Amhara Bureau of Agriculture and Rural Development Office, Ethiopia
2College of Veterinary Medicine, Mekelle University, P.O. Box 231, Mekelle, Ethiopia
3College of Veterinary Medicine, Gonder University, Gondar, Ethiopia

Received 11 August 2014; Revised 20 January 2015; Accepted 20 January 2015

Academic Editor: Tongzhang Zheng

Copyright © 2015 Yibeltal Terefe et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. Schönian, I. Mauricio, and E. Cupolillo, “Is it time to revise the nomenclature of Leishmania?” Trends in Parasitology, vol. 26, no. 10, pp. 466–469, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. G. Matlashewski, B. Arana, A. Kroeger et al., “Miltefosine promotes IFNgamma dominated anti leishmanial immune response,visceral leishmaniasis,” The Journal of Immunology, vol. 182, pp. 7146–7154, 2011. View at Google Scholar · View at Scopus
  3. WHO, Control of the Leishmaniasis. Report of a Meeting of the WHO Expert Committee on the Control of Leishmaniasis, World Health Organization, Geneva, Switzerland, 2010.
  4. A. U. Bari and S. B. Rahman, “Cutaneous leishmaniasis: an overview of parasitology and host-parasite-vector inter relationship,” Journal of Pakistan Association of Dermatologists, vol. 18, no. 1, pp. 42–48, 2008. View at Google Scholar · View at Scopus
  5. F. Frézard, C. Demicheli, and R. R. Ribeiro, “Pentavalent antimonials: new perspectives for old drugs,” Molecules, vol. 14, no. 7, pp. 2317–2336, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. M. Shahian and A. Alborzi, “Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children,” Medical Science Monitor, vol. 15, no. 6, pp. CR290–CR293, 2009. View at Google Scholar · View at Scopus
  7. M. I. S. Lima, V. O. Arruda, E. V. C. Alves, A. P. S. de Azevedo, S. G. Monteiro, and S. R. F. Pereira, “Genotoxic effects of the antileishmanial drug glucantime,” Archives of Toxicology, vol. 84, no. 3, pp. 227–232, 2010. View at Publisher · View at Google Scholar · View at Scopus
  8. L. Carvalho, J. R. Luque-Ortega, C. López-Martín, S. Castanys, L. Rivas, and F. Gamarro, “The 8-aminoquinoline analogue sitamaquine causes oxidative stress in Leishmania donovani promastigotes by targeting succinate dehydrogenase,” Antimicrobial Agents and Chemotherapy, vol. 55, no. 9, pp. 4204–4210, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Bashaye, N. Nombela, D. Argaw et al., “Risk factors for visceral leishmaniasis in a new epidemic site in Amhara region, Ethiopia,” The American Journal of Tropical Medicine and Hygiene, vol. 81, no. 1, pp. 34–39, 2009. View at Google Scholar · View at Scopus
  10. R. ter Horst, S. M. Collin, K. Ritmeijer, A. Bogale, and R. N. Davidson, “Concordant HIV infection and visceral leishmaniasis in Ethiopia: the influence of antiretroviral treatment and other factors on outcome,” Clinical Infectious Diseases, vol. 46, no. 11, pp. 1702–1709, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. CSA, National census conducted by the Central Statistical Agency of Ethiopia, 2007.
  12. ILRI, “Initial draft report, Metema pilot learning site diagnosis and program design,” 2005.
  13. K. Gkolfinopoulou, N. Bitsolas, S. Patrinos et al., “Epidemiology of human leishmaniasis in Greece, 1981–2011,” Eurosurveillance, vol. 18, no. 29, article 4, 2013. View at Google Scholar · View at Scopus
  14. R. Horst, T. Tefera, G. Assefa, A. Z. Ebrahim, R. N. Davidson, and K. Ritmeijer, “Field evaluation of rK39 test and direct agglutination test for diagnosis of visceral leishmaniasis in a population with high prevalence of human immunodeficiency virus in Ethiopia,” The American Journal of Tropical Medicine and Hygiene, vol. 80, no. 6, pp. 929–934, 2009. View at Google Scholar · View at Scopus
  15. D. Argaw, A. Mulugeta, M. Herrero et al., “Risk factors for visceral leishmaniasis among residents and migrants in Kafta-Humera, Ethiopia,” PLoS Neglected Tropical Diseases, vol. 7, no. 11, Article ID e2543, 2013. View at Publisher · View at Google Scholar
  16. B. K. A. Borges, J. A. da Silva, J. P. A. Haddad et al., “Assessment of knowledge and preventive attitudes concerning visceral leishmaniasis in Belo Horizonte, Minas Gerais State, Brazil,” Cadernos de Saude Publica, vol. 24, no. 4, pp. 777–784, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. D. E. A. Elnaiem, “Ecology and control of the sand fly vectors of Leishmania donovani in East Africa, with special emphasis on Phlebotomus orientalis,” Journal of Vector Ecology, vol. 36, no. 1, pp. S23–S31, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. MOH, Ethiopia National Malaria Indicator Survey Technical Summary, MOH, Addis Ababa, Ethiopia, 2011.
  19. S.-H. Moosa-Kazemi, M.-R. Yaghoobi-Ershadi, A.-A. Akhavan et al., “Deltamethrin-impregnated bed nets and curtains in an anthroponotic cutaneous leishmaniasis control program in northeastern Iran,” Annals of Saudi Medicine, vol. 27, no. 1, pp. 6–12, 2007. View at Publisher · View at Google Scholar · View at Scopus